Optimizing Blood Pressure Control: A Randomized Comparative Trial of Losartan/Chlorthalidone vs. Losartan/Hydrochlorothiazide

Abstract Introduction Cardiovascular diseases are a leading cause of global mortality, with hypertension as a major risk factor. Low control rates are often attributed to monotherapy, while evidence and clinical guidelines support the effectiveness of combination therapies. This study aimed to evalu...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Isabel E. Rucker-Joerg, Ernesto G. Cardona-Muñoz, Francisco G. Padilla-Padilla, Rodrigo Suarez-Otero, Yulia Romero-Antonio, Emmanuel Canales-Vázquez, Kevin F. Rios-Brito, Ileana C. Rodríguez-Vazquez, Jorge González-Canudas
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Adis, Springer Healthcare 2025-04-01
Ráidu:	Cardiology and Therapy
Fáttát:	Hypertension Cardiovascular disease Losartan Chlorthalidone Hydrochlorothiazide
Liŋkkat:	https://doi.org/10.1007/s40119-025-00407-7
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!